Hologic(HOLX)

MARLBOROUGH, MAMedical Devices1 H-1B visas (FY2023)

Focus: Hologic is a $4B+ public medical device company headquartered in Massachusetts, specializing in women's health diagnostics and surgical systems. The company operates across breast imaging, gynecological, and urological device portfolios with significant installed base in clinical and hospital settings.

Profile data last refreshed 17h ago · AI intelligence enriched 1w ago

Funding Stage

PUBLIC

Employees

5001-10000

Open Jobs

About Hologic

AI assessmentNot Hiring

No open roles listed right now. Follow Hologic to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

4/9 — Basic

Company HealthStrong

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Revenue

$4.0B

Pipeline & Clinical Trials

3D mammograpgy system

Breast Cancer

N/A

Clinical Trials (1)

NCT00990483A Comparison of the 15 and 30 Acquisition Angle Breast Tomosynthesis Mammography for Breast Abnormalities

N/A

Help build intelligence for Hologic

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Established $4B revenue base with $2.2B cash reserves provides financial stability and resources for R&D investment in women's health focus areas.
Diversified portfolio across imaging (digital tomosynthesis, diagnostic systems) and surgical devices (NovaSure, MammoSite) reduces single-product dependency risk.
Mid-stage pipeline with active Phase 2 programs (GliaSite, MammoSite) and diagnostic innovation trials offer technical depth in oncology and women's health.

Watch Out For

Revenue declined 18% YoY ($4.9B to $4.0B in FY 2025) and net income fell 65% ($1.3B to $456M), signaling margin pressure or operational headwinds that may constrain hiring and advancement.
R&D intensity of only 7% ($294M on $4B revenue) is below specialty med-device peers, suggesting limited innovation velocity and fewer early-stage development opportunities for ambitious scientists.

Generated by Claude from Hologic's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Hysteroscopic Morcellator

Uterine Fibroids

N/A

Clinical Trials (1)

NCT00979342Comparative Sedation Study of the MyoSure Hysteroscopic Tissue Removal System

N/A

MyoSure Tissue Removal System

Uterine Fibroids

N/A

Clinical Trials (1)

NCT01369758MyoSure Hysteroscopic Tissue Removal System Registry Study

N/A

Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quant

Hepatitis B, Chronic

N/A

Clinical Trials (1)

NCT02167113Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay

N/A

Hologic Selenia Dimensions Digital Breast Tomosynthesis System

Breast Cancer

N/A

Clinical Trials (1)

NCT00971087Multicenter Hologic Tomosynthesis Study

N/A

Genesis and Gemini

Breast Cancer

N/A

Clinical Trials (1)

NCT00759447A Pilot Study - Comparison of Two Hologic 3D Mammography Systems

N/A

Myomectomy

Uterine Fibroids

N/A

Clinical Trials (1)

NCT01152112HOME Study: Hysteroscopic Office Myomectomy Evaluation

N/A

2D Mammogram

Breast Density

N/A

Clinical Trials (1)

NCT01086241Tomosynthesis in Screening Mammography

N/A

Prediction of Spontaneous Onset of Labor at Term

Labor, Induced

N/A

Clinical Trials (1)

NCT05109247Prediction of Spontaneous Onset of Labor at Term

N/A

selective bladder denervation using RF energy

Urgent Urinary Incontinence

N/A

Clinical Trials (1)

NCT04408352RF Ablation of the Trigone for the Treatment of UUI

N/A

Digital breast tomosynthesis

Recall Rate

N/A

Clinical Trials (1)

NCT01248546Tomosynthesis in the Oslo Breast Cancer Screening Program

N/A

Firefighter Cardiorespiratory Fitness (CRF) Pilot Study

Cardiorespiratory Fitness

N/A

Clinical Trials (1)

NCT03585335Firefighter Cardiorespiratory Fitness (CRF) Pilot Study

N/A

fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth

Pre-term Birth

N/A

Clinical Trials (1)

NCT01955148fFN Clinical Evaluation in Asymptomatic Women at High Risk for Preterm Birth

N/A

Adiana Transcervical Sterilization System

Reproductive Sterilization

N/A

Clinical Trials (1)

NCT00737061Safety & Efficacy Study of the Adiana System for Women Who Desire Permanent Birth Control (Sterilization)

N/A

Mammography

N/A

Clinical Trials (1)

NCT05199701Prospective Case Collection Study for New Mammography Technologies

N/A

RF Treatment

Adenomyosis

N/A

Clinical Trials (1)

NCT05130190Radiofrequency Ablation of Adenomyosis

N/A

NovaSure

Menorrhagia

N/A

Clinical Trials (1)

NCT01124357A Study to Compare the Effectiveness of Two Different Outpatient Endometrial Ablation Techniques Used for Heavy Periods

N/A

NovaSure Endometrial Ablation

Menorrhagia

N/A

Clinical Trials (1)

NCT01934244Post Approval NovaSure Essure Labeling Study

N/A

Interlace Medical 1st Generation Hysteroscopic Morcellator

Abnormal Uterine Bleeding

N/A

Clinical Trials (1)

NCT01026805Clinical Evaluation of the Interlace Medical Hysteroscopic Morcellator

N/A

Perilynx Analyzer to measure AF and VF fluid

Intra-Amniotic Infection of Foetus

N/A

Clinical Trials (1)

NCT03497234Rapid Amniotic Fluid (AF) Test and a Non-Invasive Vaginal Fluid (VF) Test

N/A

Thinprep® LBC

Human Papilloma Virus Infection

N/A

Clinical Trials (1)

NCT02634190Clinical Evaluation of the APTIMA® HPV Assay and Comparison With the HR HC2® Test Using LBC ThinPrep® Specimens

N/A

Screening To Obviate Preterm Birth

Preterm Labor

N/A

Clinical Trials (1)

NCT01868308Screening To Obviate Preterm Birth

N/A

CEM Software in New Mammography Device

Breast Screening

N/A

Clinical Trials (1)

NCT06636539Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device

N/A

VF-Test

Preterm Birth

N/A

Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Ca

Ductal Carcinoma In Situ

N/A

Clinical Trials (1)

NCT01060085Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging

N/A

Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples

Chlamydia Trachomatis

N/A

Clinical Trials (1)

NCT02795975Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples

N/A

Comparison of Fetal Fibronectin (fFN) Specimen Collection Methodologies: With Speculum Versus Withou

Preterm Delivery

N/A

Clinical Trials (1)

NCT00883324Comparison of Fetal Fibronectin (fFN) Specimen Collection Methodologies: With Speculum Versus Without Speculum

N/A

Adiana Post-Approval Clinical Study (APACS)

Women Contraception

N/A

Clinical Trials (1)

NCT01177670Adiana Post-Approval Clinical Study (APACS)

N/A

Ultra Dual-Energy X-ray Absorptiometry (DXA): Accurate and Precise Quantitative Multi-compartment Bo

Body Composition

N/A

Clinical Trials (1)

NCT03430323Ultra Dual-Energy X-ray Absorptiometry (DXA): Accurate and Precise Quantitative Multi-compartment Body Composition

N/A

Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects

Herpes Simplex Infections

N/A

Clinical Trials (1)

NCT02270099Evaluation of the HSV 1 & 2 Assay in Specimens From Symptomatic Subjects

N/A

vaginoscopy

Leiomyoma of Uterus

N/A

Clinical Trials (1)

NCT04373694Vaginoscopy Compared to Traditional Hysteroscopy for Hysteroscopy Morcellation in Outpatient Clinic. A Randomized Trial

N/A

Hologic's Genius Digital Diagnostics System

Cervical Cancer Screening

N/A

Clinical Trials (1)

NCT04965857Comparison of the Hologic Genius Digital Diagnostics System With the Liquid-based Cytology (LBC) Manual Microscopy

N/A

Efficacy of Tomosynthesis in the BIRADS 3 Population

Breast Cancer

N/A

Clinical Trials (1)

NCT00763100Efficacy of Tomosynthesis in the BIRADS 3 Population

N/A

Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study

Breast Cancer

N/A

Clinical Trials (1)

NCT01433640Dual-energy Contrast-enhanced (2D and 3D Mammography Versus Contrast-enhanced MRI)- A Pilot Study

N/A

Digital Breast Tomosynthesis

Breast Cancer Screening

N/A

Clinical Trials (1)

NCT06059300Digital Breast Tomosynthesis for the Dutch National Breast Cancer Screening Program

N/A

Hologic's Genius Digital Diagnostics System

Cervical Cancer Screening

N/A

Clinical Trials (1)

NCT05000125Comparison of the Hologic Genius Digital Diagnostics System With the ThinPrep Imaging System

N/A

Standard of Care Flat Paddle

Breast Cancer

N/A

Clinical Trials (1)

NCT03611543Evaluating Image Quality and Comfort of an Investigational Curved Paddle Compared to a Standard Paddle

N/A

Brevera Breast Biopsy System

Breast Cancer Female

N/A

Clinical Trials (1)

NCT03456583Brevera™ Breast Biopsy System Data Collection Study

N/A

Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis

Hepatitis C

N/A

Clinical Trials (1)

NCT02068963Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing

N/A

Contrast Enhanced Stereotactic Biopsy

Breast Cancer

N/A

Clinical Trials (1)

NCT06062992Contrast-Enhanced Stereotactic Biopsy

N/A

Trident Specimen Radiography System

Breast Cancer

N/A

Clinical Trials (1)

NCT01379092An Evaluation of a Self-contained Direct Digital Radiography System for Breast Specimen Imaging

N/A

Tomosynthesis

Breast Cancer

N/A

Clinical Trials (1)

NCT01669148Breast Cancer Detection: Comparison of Breast Tomosynthesis and Conventional Mammography

N/A

Fine needle aspiration and core biopsy of lymph node

Focus: Breast Cancer With Axillary Node Metastasis

N/A

Clinical Trials (1)

NCT01920139Ultrasound Guided Core Biopsy vs Fine Needle Aspiration for Evaluation of Axillary Lymphadenopathy

N/A

A Comparison of Recall Rates Between Conventional 2d Mammography and 2d Plus 3d (Tomosynthesis) Mamm

Breast Cancer

N/A

Clinical Trials (1)

NCT01569802A Comparison of Recall Rates Between Conventional 2d Mammography and 2d Plus 3d (Tomosynthesis) Mammography in a Screening Population

N/A

Comparison Study of Breast Tomosynthesis Slice Thicknesses

Breast Cancer

N/A

Clinical Trials (1)

NCT00957567Comparison Study of Breast Tomosynthesis Slice Thicknesses

N/A

Breast Biopsy

Breast Cancer Female

N/A

Clinical Trials (1)

NCT03300206A Post-Market Clinical Trial to Evaluate the Performance and Operation of the Brevera Breast Biopsy System

N/A

Tomosynthesis Breast Scanning

Breast Cancer

N/A

Clinical Trials (1)

NCT01852032Computed Tomography Versus Standard 2D Mammography Versus 3D Tomosynthesis

N/A

DXA scan of hip

Osteoporosis

N/A

Clinical Trials (1)

NCT006666403D Imaging of the Hip Using DXA

N/A

Affirm Contrast Biopsy procedure

Breast Cancer

N/A

Clinical Trials (1)

NCT04671329A Prospective, Multi-site Clinical Study to Collect User Feedback Using Affirm® Contrast Biopsy

N/A

Tomosynthesis digital mammography imaging system

Breast Cancer

N/A

Clinical Trials (1)

NCT00754598Evaluation of a 3-D Tomosynthesis Mammography System Used in Conjunction With Conventional 2-D Digital Mammography

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 53 clinical trials

Top TAs: Oncology, Women's Health, Infectious Diseases

H-1B (2023): 1 approval

Publications: 30 in PubMed

SEC Filings: 2 available

Therapeutic Area Focus

23 pipeline

4 pipeline

2 pipeline

1 pipeline

1 pipeline

Financials (FY2025)

Revenue

$4.0B17%

R&D Spend

$294M(7%)4%

Net Income

$456M

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub

Risk Signals

Recent news indicates Blackstone and TPG are seeking to divest Hologic's surgical unit for over $4 billion, suggesting potential restructuring and job transitions in that division.

Potential sale/spin of surgical operations creates medium-term uncertainty for careers in that business unit; diagnostic imaging division appears more stable.

Research Publications(10)

Recent peer-reviewed publications with author affiliations at this company

Development and genomic characterization of a diverse HIV-1 variant reference panel for nucleic acid-based testing.

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology

2026

PMID:41990403

Mycoplasma genitalium infection and adverse perinatal outcomes.

American journal of obstetrics and gynecology

2026

PMID:42097190

Showing 5 of 10 publications

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Hologic(HOLX)

About Hologic

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Recent News · Hologic(10)

Open Jobs (0)

Financials (FY2025)

Hiring Trend

Visa Sponsorship

Risk Signals

Research Publications(10)